Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Myasthenia Gravis 4Carcinoma, Hepatocellular 2Skin Neoplasms 1Nervous System Diseases 1Melanoma 1Hepatitis 1Colitis 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Azathioprine × Clear all
NCT02081755 2026-01-27

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Baylor Research Institute

Phase 4 Enrolling by invitation
336 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00355862 2014-07-30

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

University of Regensburg

Phase 3 Completed
525 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡